0000902664-18-002549.txt : 20180612
0000902664-18-002549.hdr.sgml : 20180612
20180612135737
ACCESSION NUMBER: 0000902664-18-002549
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180611
FILED AS OF DATE: 20180612
DATE AS OF CHANGE: 20180612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Select Advisor LLC
CENTRAL INDEX KEY: 0001633313
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 18894172
BUSINESS ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: SUITE 2802
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-937-4975
MAIL ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: SUITE 2802
CITY: NEW YORK
STATE: NY
ZIP: 10036
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aghazadeh Behzad
CENTRAL INDEX KEY: 0001701815
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 18894173
MAIL ADDRESS:
STREET 1: C/O VENBIO SELECT ADVISOR LLC
STREET 2: 120 W. 45TH STREET, 28TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
p18-1318form4.xml
MIRATI THERAPEUTICS, INC.
X0306
4
2018-06-11
0
0001576263
Mirati Therapeutics, Inc.
MRTX
0001633313
venBio Select Advisor LLC
120 WEST 45TH STREET
SUITE 2802
NEW YORK
NY
10036
0
0
1
0
0001701815
Aghazadeh Behzad
C/O VENBIO SELECT ADVISOR LLC
120 W. 45TH STREET, 28TH FLOOR
NEW YORK
NY
10036
0
0
1
0
Common Stock, $0.001 par value per share ("Common Stock")
2018-06-11
4
P
0
400000
38.85
A
4798101
I
See footnotes
Warrant (right to buy)
.001
2018-06-11
4
P
0
63235
38.849
D
2018-06-11
Common Stock
63235
63235
I
See footnotes
The securities reported herein are held on behalf of accounts managed by venBio Select Advisor LLC, a Delaware limited liability company (the "Investment Manager") and venBio Select Fund LLC, a Delaware limited liability company, a fund managed by the Investment Manager. Behzad Aghazadeh ("Dr. Aghazadeh," and together with the Investment Manager, the "Reporting Persons") serves as the portfolio manager and controlling person of the Investment Manager.
The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
These warrants can be exercised at any time.
venBio Select Advisor LLC, by: /s/ Scott Epstein, its Chief Financial Officer & Chief Compliance Officer
2018-06-12
/s/ Behzad Aghazadeh
2018-06-12